Mutual Fund Details
NAV
₹41.1960
as on 22 Nov 2024, 11:20 PM
₹0.4600(1.13%)
Last Change
Scheme Ratings
3
Pharma
5Y Returns
3
rated by Value Research
Pharma
Rankings based on 5Y Returns | as on 18 Nov 2024
×
1
DSP Healthcare Fund Direct - Growth
32.39%
2
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Direct - Growth
31.24%
3
Mirae Asset Healthcare Fund Direct - Growth
30.28%
4
SBI Healthcare Opportunities Fund Direct Plan-Growth
29.84%
5
UTI Healthcare Fund Direct-Growth
28.78%
Investment Performance
would have given a return of
₹1,10,871
₹1,21,647
₹1,64,993
₹1,72,578
Bank Account
Fixed Deposit
Regular Mutual Fund
This Fund on Paytm Money
This Mutual Fund
₹72,578
Profit (absolute return)
72.58%
in the last
1m
3m
1y
3y
5y
max
+1% Higher Returns
With Direct Plans on Paytm MoneyInvestment Returns
In the last 3 months
0.87%
In the last 6 months
18.82%
In the last 1 year
39.00%
In the last 3 years
72.58%
In the last 5 years
275.84%
In the last 10 years
NA
Absolute Returns
CAGR
Scheme Riskometer
low
low to moderate
moderate
moderately high
high
very high
Investors understand that their principal will be at very high risk
Scheme Information
Mirae Asset Healthcare Fund Direct - Growth
as of 31 Oct 2024, 05:30 AM
₹2,770.21 Cr
Scheme Asset Size
Fund Type
Open-End
Exit Load
Exit load of 1% if redeemed within 1 year.
0.49%
Expense Ratio
Plan
Growth
Benchmark
BSE Healthcare Total Return Index
Exit Load
Exit load of 1% if redeemed within 1 year.
Scheme Document
Sectors Holding in this Mutual Fund
as on 31 Oct 2024
Healthcare
97.71%
₹2,706.88 Cr
Cash Holding
0.91%
₹25.28 Cr
Chemicals
0.81%
₹22.33 Cr
Diversified
0.56%
₹15.50 Cr
Others
0.01%
₹27.70 Lakh
Companies Holding in this Mutual Fund
as on 31 Oct 2024
Sun Pharmaceutical Industries Ltd.
12.90%
₹357.36 Cr
Cipla Ltd.
9.49%
₹262.89 Cr
Aurobindo Pharma Ltd.
9.34%
₹258.74 Cr
Dr. Reddy's Laboratories Ltd.
7.44%
₹206.10 Cr
Apollo Hospitals Enterprise Ltd.
6.11%
₹169.26 Cr
Others
54.72%
₹1,515.86 Cr
View All
View All
Companies Holding in this Mutual Fund
as on 31 Oct 2024
Sun Pharmaceutical Industries Ltd.
12.90%
₹357.36 Cr
Cipla Ltd.
9.49%
₹262.89 Cr
Aurobindo Pharma Ltd.
9.34%
₹258.74 Cr
Dr. Reddy's Laboratories Ltd.
7.44%
₹206.10 Cr
Apollo Hospitals Enterprise Ltd.
6.11%
₹169.26 Cr
Others
54.72%
₹1,515.86 Cr
View All
View All
This fund's returns:
19.93%Return Duration
3 Years
SBI Healthcare Opportunities Fund Direct Plan-Growth
EquityPharma
Min. Investment
₹500
Category Returns
16.33%
25.66%
3Y Returns
25.66
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Direct - Growth
EquityPharma
Min. Investment
₹100
Category Returns
16.33%
25.66%
3Y Returns
25.52
DSP Healthcare Fund Direct - Growth
EquityPharma
Min. Investment
₹100
Category Returns
16.33%
25.66%
3Y Returns
24.50
About Mirae Asset Healthcare Fund Direct - Growth
Mirae Asset Healthcare Fund Direct - Growth is a Equity mutual fund scheme from Mirae Asset Mutual Fund. This scheme was launched on Invalid date. It has an AUM of ₹2,770.21 Crores and the latest NAV decalared is ₹41.196 as on 23 Nov 2024 at 10:23 pm.
Mirae Asset Healthcare Fund Direct - Growth scheme return performance in last 1 year is 39.00%, in last 3 years is 72.58% and 309.50% since scheme launch. The min. SIP amount to invest in this scheme is ₹100.
Scheme Details
| AUM: | ₹2,770.21 Cr |
| Category: | Equity: Sectoral-Pharma |
| Launch Date: | Invalid date |
| Fund Type: | Open-End |
AMC Information
Mirae Asset Mutual Fund
View AMC Details
₹1,90,651.91 Cr
AUM
117
Schemes
Address
Unit No.606 - 6th Floor,Windsor Building - Off. CST Road,Kalina, Santacruz (East),400098
Phone Number
Phone : 022-67800301 / 1800-2090-777
Email / Website
Start investing in minutes
Download app to Explore
Scan this QR code to download the app now!
Or download from
